James V Cassella Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James V Cassella.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James V Cassella. James V Cassella is SVP, Research & Development in Alexza Pharmaceuticals Inc. ($ALXA) and Chief Development Officer in CONCERT PHARMACEUTICALS, INC. ($CNCE) and Director in Trevi Therapeutics, Inc. ($TRVI).
Latest Insider Trading Transactions of James V Cassella
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALXA, CNCE, TRVI
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17 2021 | CNCE | CONCERT PHARMACEUT ... | Cassella James V | Chief Development O ... | Sell | S | 7.32 | 3,763 | 27,545 | 94,064 | 97.8 K to 94.1 K (-3.85 %) |
| Jan 07 2021 | CNCE | CONCERT PHARMACEUT ... | Cassella James V | Chief Development O ... | Option Exercise | A | 13.07 | 60,400 | 789,428 | 60,400 | |
| Jan 07 2021 | CNCE | CONCERT PHARMACEUT ... | Cassella James V | Chief Development O ... | Grant | A | 0.00 | 21,700 | 0 | 97,827 | 76.1 K to 97.8 K (+28.50 %) |
| Aug 19 2020 | CNCE | CONCERT PHARMACEUT ... | Cassella James V | Chief Development O ... | Sell | S | 10.37 | 4,354 | 45,151 | 76,127 | 80.5 K to 76.1 K (-5.41 %) |
| Feb 19 2020 | CNCE | CONCERT PHARMACEUT ... | Cassella James V | Chief Development O ... | Option Exercise | A | 10.87 | 42,430 | 461,214 | 42,430 | |
| Feb 19 2020 | CNCE | CONCERT PHARMACEUT ... | Cassella James V | Chief Development O ... | Grant | A | 0.00 | 28,216 | 0 | 80,481 | 52.3 K to 80.5 K (+53.99 %) |
| Feb 18 2020 | TRVI | Trevi Therapeutics ... | Cassella James V | Director | Option Exercise | A | 5.50 | 23,684 | 130,262 | 23,684 | |
| Aug 19 2019 | CNCE | CONCERT PHARMACEUT ... | Cassella James V | Chief Development O ... | Grant | A | 0.00 | 31,100 | 0 | 52,265 | 21.2 K to 52.3 K (+146.94 %) |
| Jan 08 2019 | CNCE | CONCERT PHARMACEUT ... | Cassella James V | Chief Development O ... | Option Exercise | A | 13.93 | 75,000 | 1,044,750 | 75,000 | |
| Apr 19 2018 | CNCE | CONCERT PHARMACEUT ... | Cassella James V | Chief Development O ... | Sell | S | 20.18 | 10,582 | 213,510 | 30,000 | 40.6 K to 30 K (-26.08 %) |
| Apr 03 2018 | CNCE | CONCERT PHARMACEUT ... | Cassella James V | Chief Development O ... | Payment of Exercise | F | 22.90 | 4,418 | 101,172 | 55,582 | 60 K to 55.6 K (-7.36 %) |
| Jan 08 2018 | CNCE | CONCERT PHARMACEUT ... | Cassella James V | Chief Development O ... | Option Exercise | A | 27.59 | 49,500 | 1,365,705 | 49,500 | |
| Jul 10 2017 | CNCE | CONCERT PHARMACEUT ... | Cassella James V | Chief Development O ... | Grant | A | 0.00 | 60,000 | 0 | 60,000 | 0 to 60 K |
| Jan 06 2017 | CNCE | CONCERT PHARMACEUT ... | Cassella James V | Chief Development O ... | Option Exercise | A | 10.97 | 70,000 | 767,900 | 70,000 | |
| Jan 08 2016 | CNCE | CONCERT PHARMACEUT ... | Cassella James V | Chief Development O ... | Option Exercise | A | 16.85 | 50,000 | 842,500 | 50,000 | |
| Mar 06 2015 | CNCE | CONCERT PHARMACEUT ... | Cassella James V | Chief Development O ... | Option Exercise | A | 14.46 | 140,000 | 2,024,400 | 140,000 | |
| Jan 08 2008 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | A | 7.50 | 4,696 | 35,220 | 4,696 | |
| Jul 26 2007 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | A | 8.89 | 45,000 | 400,050 | 45,000 | |
| Jan 08 2007 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | A | 11.70 | 2,856 | 33,415 | 2,856 | |
| Aug 30 2006 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | A | 7.20 | 39,000 | 280,800 | 39,000 | |
| Mar 14 2006 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | J | 1.38 | 27,119 | 37,424 | 27,119 | |
| Mar 14 2006 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | J | 8.00 | 16,517 | 132,136 | 16,517 | |
| Mar 14 2006 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | J | 8.00 | 109,090 | 872,720 | 109,090 |
Page: 1